|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBSCO_ocn898769669 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
141227s2014 mau ob 001 0 eng d |
010 |
|
|
|a 2014017116
|
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d YDXCP
|d E7B
|d CCO
|d OCLCO
|d DEBSZ
|d OCLCQ
|d AZK
|d OCLCQ
|d COCUF
|d PIFAG
|d ZCU
|d MERUC
|d DEGRU
|d U3W
|d UIU
|d STF
|d OCLCF
|d OCLCQ
|d ICG
|d VT2
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCA
|d TKN
|d LEAUB
|d DKC
|d OCLCO
|d OCLCQ
|d UX1
|d OCLCQ
|d N$T
|d OCLCA
|d K6U
|d U9X
|d VLY
|d AUD
|d BRF
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d QGK
|d OCLCO
|
019 |
|
|
|a 899591384
|a 961511398
|a 962631912
|a 979584791
|a 1055394992
|a 1066651588
|a 1081296984
|a 1107345909
|a 1162496816
|a 1228564800
|a 1259054791
|
020 |
|
|
|a 311028328X
|
020 |
|
|
|a 9783110283297
|
020 |
|
|
|a 3110283298
|
020 |
|
|
|a 9783110283280
|q (electronic bk.)
|
020 |
|
|
|z 9783110367645
|
020 |
|
|
|z 3110367645
|
020 |
|
|
|a 3110381591
|
020 |
|
|
|a 9783110381597
|
024 |
7 |
|
|a 10.1515/9783110283280
|2 doi
|
029 |
1 |
|
|a AU@
|b 000056057008
|
029 |
1 |
|
|a DEBBG
|b BV044068149
|
029 |
1 |
|
|a DEBSZ
|b 43481119X
|
035 |
|
|
|a (OCoLC)898769669
|z (OCoLC)899591384
|z (OCoLC)961511398
|z (OCoLC)962631912
|z (OCoLC)979584791
|z (OCoLC)1055394992
|z (OCoLC)1066651588
|z (OCoLC)1081296984
|z (OCoLC)1107345909
|z (OCoLC)1162496816
|z (OCoLC)1228564800
|z (OCoLC)1259054791
|
050 |
|
4 |
|a R853.C55
|b S37 2014eb
|
060 |
|
4 |
|a W 20.5
|
072 |
|
7 |
|a MED106000
|2 bisacsh
|
082 |
0 |
4 |
|a 610.72/4
|2 23
|
084 |
|
|
|a PZ 4700
|2 rvk
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Schriever, Karl-Heinz.
|
245 |
1 |
0 |
|a G3P - Good Privacy Protection Practice in Clinical Research :
|b Principles of Pseudonymization and Anonymization.
|
260 |
|
|
|a Berlin/Boston :
|b De Gruyter,
|c 2014.
|
300 |
|
|
|a 1 online resource (210 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a About the Authors; 1 Introduction; 2 Study Modes; 2.1 Screening Mode -- Pharmacogenetic Information for Screening; 2.2 Pre- Unspecified Mode -- Pharmacogenetic as Part of a Study; 2.3 Possible Approaches, Summary -- Clinical Trial With Genetic Part; 2.4 Biobanks -- What do we Mean by That?; 3 Protection Masks and Procedures; 3.1 Identified Samples/Data; 3.2 De-identified Samples/Data; 3.3 Anonymized Samples/Data; 3.4 Re-identification; 4 Coding Methods for De-identified Samples/Data; 4.1 Single-coded Samples/Data; 4.2 Double-coded Samples/Data; 4.3 Triple-coded Samples/Data.
|
505 |
8 |
|
|a 5 Relationships Among the Protection Masks6 Data Types; 7 Anonymization; 7.1 Basic Terms and Ideas; 7.2 Masking; 7.3 Discarding the Key; 7.4 Maintaining the Reliability of Stored Data; 7.5 Security Measures; 8 Validation -- a Brief Introduction; 8.1 Preliminaries; 8.2 Basic Definitions & Terms; 8.3 General Principles of Computer System Validation; 8.4 Primary Validation -- Specification Phase; 8.5 Primary Validation -- Preparing Operational Use; 8.6 Primary Validation -- Testing Phase; 9 Request Management; 9.1 Genetic Review Board (GRB); 9.2 Request Specification; 9.3 Subrequest Specification.
|
505 |
8 |
|
|a 9.4 Involvement of External Service Providers10 Legal Requirements & Regulations; 10.1 Basic Ideas; 10.2 Data Protection in the European Union (EU); 10.3 Transfer of Personal Data to Third Countries; 10.4 Binding Corporate Rules; 10.5 Data Protection in the United States (U.S.) -- a Brief History; 11 Informed Consent; 11.1 Sections Mandatory for a Genetic Informed Consent; 12 Selected Data Protection & Medical Sites; 12.1 Germany; 12.2 Europe; 12.3 US; 12.4 Global Initiatives; 13 Impact of External Services on Data Protection; 13.1 Introduction; 13.2 Scenario 1 -- Using GDI Throughout.
|
505 |
8 |
|
|a 13.3 Scenario 2 -- Replacing GDI by nGDI Upon Sample Registration, Performed by regCRO13.4 Scenario 3 -- Replacing GDI by nGDI Upon Sample Registration, Performed by Sponsor; 13.5 Scenario 4 -- Sample Registration by CRO, Proprietary Labeling with CROSID; 13.6 Scenario 5 -- Barcoded Label bSID at Study Site; 13.7 Overall Summary; 13.8 External Statistical Evaluation; 13.9 External Biobanking; 14 Practical Approach to Clinical Trials with Supplementary Genetic Parts; 14.1 Introduction; 14.2 Overall Project Topology; 14.3 Checklist -- Trial Set-up; 14.4 Checklist -- System Topology.
|
505 |
8 |
|
|a 14.5 Checklist -- Sample Management14.6 Checklist -- ICs, Ethics Committees Restrictions; 14.7 Checklist -- Anonymization; 14.8 Checklist -- Statistical Evaluation; 15 Appendix 1: Data Protection in the European Union; 15.1 Council of Europe (COE); 15.2 EU Privacy Directive -- Definitions; 15.3 Tasks of the Article 29 Data Protection Working Party; 16 Appendix 2: Data Types; 16.1 EU Privacy Directive (October 24, 1995); 16.2 Council of Europe (COE) Definition of Data Types; 16.3 Federal Data Protection Act (GER) as of 1. Jan. 2003; 17 Appendix 3: Protection Masks.
|
500 |
|
|
|a 17.1 EMA definition of anonymous sample/data.
|
520 |
|
|
|a Medical and genetic information from medical research must be protected against unauthorized access and replication. This book is a practical guide demonstrating how coding methods, providing the required high degree of data protection, can be integrated into respective applications dealing with patient related medical and genetic data.
|
504 |
|
|
|a Includes bibliographical references (pages 191-196) and index.
|
546 |
|
|
|a English.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Clinical trials
|x Research.
|
650 |
|
0 |
|a Data protection.
|
650 |
|
0 |
|a Medical care
|x Research.
|
650 |
|
0 |
|a Medical records
|x Access control.
|
650 |
|
0 |
|a Privacy, Right of.
|
650 |
|
0 |
|a Confidential communications.
|
650 |
1 |
2 |
|a Biomedical Research
|
650 |
2 |
2 |
|a Anonymous Testing
|
650 |
2 |
2 |
|a Confidentiality
|
650 |
2 |
2 |
|a Privacy
|
650 |
|
6 |
|a Études cliniques
|x Recherche.
|
650 |
|
6 |
|a Protection de l'information (Informatique)
|
650 |
|
6 |
|a Soins médicaux
|x Recherche.
|
650 |
|
6 |
|a Dossiers médicaux
|x Accès
|x Contrôle.
|
650 |
|
6 |
|a Secret professionnel.
|
650 |
|
7 |
|a MEDICAL / Research.
|2 bisacsh
|
650 |
|
7 |
|a Confidential communications
|2 fast
|
650 |
|
7 |
|a Data protection
|2 fast
|
650 |
|
7 |
|a Medical care
|x Research
|2 fast
|
650 |
|
7 |
|a Medical records
|x Access control
|2 fast
|
650 |
|
7 |
|a Privacy, Right of
|2 fast
|
650 |
|
7 |
|a Medizin
|2 gnd
|
650 |
|
7 |
|a Datenschutz
|2 gnd
|
700 |
1 |
|
|a Schröder, Markus.
|
776 |
0 |
8 |
|i Print version:
|a Schriever, Karl-Heinz.
|t G3P - Good Privacy Protection Practice in Clinical Research : Principles of Pseudonymization and Anonymization.
|d Berlin/Boston : De Gruyter, ©2014
|z 9783110367645
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=909994
|z Texto completo
|
938 |
|
|
|a De Gruyter
|b DEGR
|n 9783110283280
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL1685362
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr11006632
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 11725008
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 909994
|
994 |
|
|
|a 92
|b IZTAP
|